Created in 2021 by Camille Bouget, Vincent Bouget et Julien Duquesne, Scienta Lab is a deeptech company harnessing artificial intelligence to transform the drug discovery and development process in immunology and inflammation.
With its unique and proprietary technology based on a foundation model, Scienta Lab leverages multimodal data to accelerate the discovery of new therapeutic targets and the development of personalized treatments. The company’s research activities, led in partnership with top-tier academic institutions across Europe, are regularly featured in medical journals and international congresses.
Scienta Lab is based in Biolabs Hôtel Dieu and has been selected amongst the 2023 edition of the Future 40 program which rewards the most promising startups of Station F each year. In December 2023, the company announced a seed round of € 4M from CentraleSupélec Venture and a team of world-class business angels and is thus seeking for top talents to accelerate its development.
Join us and be a part of our exciting journey to unravel the mysteries of the immune system!
Discover who we are and what we value here.